INVESTABOT
Equity Research
XNYS · SERVICES-MEDICAL LABORATORIES · SERVICES-MEDICAL LABORATORIES
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Megan D. Bailey is stepping down as Executive Vice President and President of Central Laboratories and International at Labcorp Holdings, effective September 4, 2026. Her successor is already named, suggesting an …
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-08-04. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-05-11. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one fili…
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-07-01. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-07-02. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one fili…
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-07-02. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one fili…
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-05-06. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-06-08. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one fili…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 8/11/2026 | Schechter Adam H | President & CEO | SELL | -4,669 | $320 | $1,495,808 |
| 8/4/2026 | Summy Amy B. | EVP, Chief Marketing Officer | SELL | -924 | $307 | $283,428 |
| 8/3/2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | SELL | -82 | $309 | $25,356 |
| 8/3/2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | OPTION_EXERCISE | 1,338 | $209 | $279,977 |
| 8/3/2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | SELL | -1,338 | $309 | $413,751 |
| 8/3/2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | OPTION_EXERCISE | -1,338 | — | — |
| 7/2/2026 | Kyle Kathryn W | EVP, Chief Legal Officer | SELL | -92 | $286 | $26,329 |
| 7/2/2026 | Vaughn Bryan T | EVP and President, Diagnostics | SELL | -234 | $286 | $66,968 |
| 7/1/2026 | Kyle Kathryn W | EVP, Chief Legal Officer | OPTION_EXERCISE | 256 | — | — |
| 7/1/2026 | Kyle Kathryn W | EVP, Chief Legal Officer | TAX_WITHHOLD | -73 | $284 | $20,723 |
| 7/1/2026 | Kyle Kathryn W | EVP, Chief Legal Officer | OPTION_EXERCISE | -256 | — | — |
| 7/1/2026 | Vaughn Bryan T | EVP and President, Diagnostics | OPTION_EXERCISE | 327 | — | — |
| 7/1/2026 | Vaughn Bryan T | EVP and President, Diagnostics | TAX_WITHHOLD | -93 | $284 | $26,401 |
| 7/1/2026 | Vaughn Bryan T | EVP and President, Diagnostics | OPTION_EXERCISE | -327 | — | — |
| 6/8/2026 | Kyle Kathryn W | EVP, Chief Legal Officer | SELL | -762 | $264 | $201,084 |
| 5/11/2026 | Schechter Adam H | President & CEO | SELL | -5,903 | $255 | $1,502,314 |
| 3/27/2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | SELL | -1,633 | $267 | $436,093 |
| 3/27/2026 | Meltzer Jonathan C | EVP, Operations | SELL | -839 | $267 | $224,055 |
| 3/26/2026 | Schechter Adam H | President & CEO | GRANT | 58,470 | — | — |
| 3/26/2026 | Schechter Adam H | President & CEO | TAX_WITHHOLD | -26,106 | $268 | $7,006,328 |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 8/11/2026 | Schechter Adam H | — | 4,669 | SEC |
| 8/4/2026 | Summy Amy B. | — | 924 | SEC |
| 7/2/2026 | Kyle Kathryn W | — | 92 | SEC |
| 7/2/2026 | Vaughn Bryan T | — | 234 | SEC |
| 7/1/2026 | van der Vaart Sandra D | — | 7,138 | SEC |
| 6/8/2026 | Kyle Kathryn W | — | 762 | SEC |
| 5/11/2026 | Schechter Adam H | — | 5,903 | SEC |
| 5/6/2026 | van der Vaart Sandra D | — | 6,238 | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 9,850,631 | $2,471,326,305 | — | 1/29/2026 |
| BlackRock | 9,493,144 | $1,931,949,736 | — | 8/13/2024 |
| BlackRock | 6,574,261 | $1,840,793,144 | 2.0% | 8/7/2026 |
| BlackRock | 6,444,856 | $1,719,552,130 | -1.5% | 5/13/2026 |
| BlackRock | 6,540,781 | $1,640,951,111 | — | 2/12/2026 |
| State Street | 3,907,656 | $1,094,143,680 | 1.1% | 8/7/2026 |
| State Street | 3,863,171 | $1,030,732,655 | 1.0% | 5/15/2026 |
| State Street | 3,826,327 | $959,948,918 | — | 2/13/2026 |
| Fidelity (FMR) | 1,904,870 | $533,363,743 | 47.9% | 8/13/2026 |
| Morgan Stanley | 1,609,447 | $450,646,000 | 7.4% | 8/13/2026 |
| JP Morgan Chase | 1,532,723 | $404,041,381 | 19.1% | 5/13/2026 |
| Morgan Stanley | 1,498,027 | $399,689,085 | -0.5% | 5/15/2026 |
| Morgan Stanley | 1,505,539 | $377,710,406 | — | 5/27/2026 |
| JP Morgan Chase | 1,268,384 | $354,615,328 | -17.3% | 8/12/2026 |
| Fidelity (FMR) | 1,288,411 | $343,761,092 | -3.8% | 5/15/2026 |
| Fidelity (FMR) | 1,339,745 | $336,115,348 | — | 2/17/2026 |
| JP Morgan Chase | 1,287,177 | $322,927,200 | — | 2/11/2026 |
| Goldman Sachs | 595,504 | $149,399,958 | — | 3/25/2026 |
| Goldman Sachs | 435,456 | $121,927,654 | 10.0% | 8/14/2026 |
| Goldman Sachs | 395,998 | $105,656,143 | -33.5% | 5/15/2026 |